Dr. Ramachandran is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
333 Cedar St
New Haven, CT 06510Phone+1 786-271-1531
Education & Training
The Warren Alpert Medical School of Brown UniversityClass of 2015
Certifications & Licensure
CT State Medical License 2021 - 2025
CA State Medical License 2018 - 2022- American Board of Family Medicine Family Medicine
Publications & Presentations
PubMed
- 13 citationsExtending the US Food and Drug Administration's Postmarket Authorities.Holly Fernandez Lynch, Rachel E Sachs, Sejin Lee, Matthew Herder, Joseph S Ross
JAMA Health Forum. 2023-06-02 - 2 citationsPremarket Evidence and Postmarketing Requirements for Real-Time Oncology Review Indication Approvals.Maryam Mooghali, Ayman Mohammad, Joshua D Wallach, Aaron P Mitchell, Joseph S Ross
JAMA Network Open. 2024-05-01 - 9 citationsSpending by the Centers for Medicare & Medicaid Services Before and After Confirmation of Benefit for Drugs Granted US Food and Drug Administration Accelerated Approva...Joshua J Skydel, Alexander C Egilman, Joshua D Wallach, Reshma Ramachandran, Ravi Gupta
JAMA Health Forum. 2022-05-01
Press Mentions
FDA Urged to Levy Fines for Delayed Confirmatory Trials in Oncology and BeyondOctober 30th, 2024- A $3,500 Price to Live: Why the FTC Is Suing PBMs over Insulin PricesOctober 14th, 2024
- Should FDA Grant Accelerated Approval to Duchenne Muscular Dystrophy Gene Therapy?May 18th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
